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HEART FAILURE (HF) IS A SIGNIFICANT health problem, affecting nearly one in five adults during their lifetime (11) . It is a complex systemic syndrome that can result from a wide variety of clinical conditions and is accompanied by maladaptive left ventricular remodeling. Importantly, remodeling generally begins before clinical symptoms become apparent (4, 10, 35) . Thus, a better understanding of the pathophysiological changes during asymptomatic left ventricular dysfunction is necessary for early diagnosis and therapeutic intervention. While studies of human HF and experimental animal models have identified common gene expression changes in HF (3), including upregulation of natriuretic peptides and extracellular matrix components and downregulation of mitochondrial metabolic transcripts, these changes were often identified in late stages of the disease process. Far less information is available regarding transcriptional changes during early stages of the HF continuum that are likely to have impacted the subsequent course of disease.
In this study, we hypothesized that many HF genes that show expression changes within the first few days after a cardiac insult will strikingly differ from transcripts expressed in late-stage HF with respect to functional classes, and that this will hold true across different etiologies of heart failure, e.g., myocardial ischemia, pressure overload, tachypacing, and genetic HF models. Second, we postulated that genes observed as up-or downregulated in late-stage HF may undergo the directionally opposite transition earlier in the disease. To test this, we performed a meta-analysis of heterogeneous gene expression studies from the Gene Expression Omnibus (GEO) data repository that reported data on cardiac gene expression from both early (2-3 days following a cardiac insult) and late stages of HF. The capture of the early time point provides insights into previously unappreciated transcriptional changes during the development of HF. Our results confirm transient and directionally biphasic gene expression clusters in early vs. late HF states and support differential promoter and microRNA (miRNA) regulation during these periods.
MATERIALS AND METHODS
MerCreMer mouse model. Mice expressing mutated estrogen receptor-coupled Cre under the transcriptional control of cardiacspecific myosin heavy chain [MerCreMer (MCM) 005650; Jackson Laboratories, Bar Harbor, ME] were back-crossed for Ͼ10 generations with C57Bl6/J. Transient cardiomyopathy develops in these mice following 5-day exposure to tamoxifen-free base (T5648, Sigma) as previously reported (17) , with peak dysfunction at day 10 and full recovery after 4 wk. Full transcriptome analyses (Illumina MouseRef-8v2.0 Expression BeadChip) were generated from flash-frozen left ventricular myocardium at different time points (Table 1) .
Gene expression data. Expression datasets were accessed from the GEO database (8) , which represents the largest public repository for gene expression data. We identified six studies (10, 21, 31, 37) that fulfilled the following criteria: 1) Cardiac gene expression data using arrays with Ͼ10,000 probes, providing close to whole-genome coverage, 2) HF studies for which time course data with control, early (Ͻ3 days after cardiac insult), and late time points (usually Ͼ2-3 wk) with at least five samples per group. All etiologies of HF (ischemic and nonischemic models) in different species were considered. We have included multiple species, as previous studies in mouse, rat, and dog models of HF have shown common gene expression patterns in end-stage heart failure (3). Of note, besides five mouse models of early and late HF, we have also included a time-course analysis in a canine model of tachypacing-induced HF, as it represents a large mammalian model of HF that shares many features with human HF. The inclusion of this study supports the aim of identifying a pattern of gene expression common to early HF across different HF models. Series matrix files of all six studies that fulfilled these criteria were downloaded from GEO and used in the original format submitted by the authors (normalized data). A detailed summary of these studies is listed in Table 1 .
Statistical analysis. All six studies were first analyzed separately using the original Series Matrix File data format provided in GEO. Differentially expressed genes between control, early and late HF time points were identified by multiclass Significance Analysis of Microarrays (34) , which corresponds to ANOVA with correction for multiple testing. Differences in gene expression were regarded as statistically significant if a false discovery rate of q Ͻ 0.05 was achieved. To determine various patterns of temporal gene expression, we used a correlation matrix with a cut-off of r Ͼ ϩ0.95 for positive correlation and r Ͻ Ϫ0.95 for negative correlation. The following five patterns were identified ( Fig. 1 ): 1) gradual HF: gene expression increases (for positive correlation) or decreases (for negative correlation) continuously between control, early, and late HF time points; 2) early sustained HF (early HF): gene expression increased (or decreased) at early HF vs. control, and no further change was observed at later time points; 3) late-only HF (late HF): no difference in expression between control and early time points, but significant changes in later HF; 4) transient HF: gene expression altered only early then returning to control baseline; 5) bidirectional HF (BID HF): up-or downregulation in the early HF phase that changed to the opposite pattern with late HF.
Gene expression was analyzed by KEGG (Kyoto Encyclopedia of Genes and Genomes) (16) pathways that were included in WebGestalt (Web-based GEne SeT AnaLysis Toolkit) (36) , and the Database for Annotation, Visualization and Integrated Discovery (DAVID) (12) . To include the maximum number of KEGG pathways per study, the default parameters for threshold were changed in DAVID (count Ͼ 1, EASE score 10). Subsequently, we focused our analysis on 193 major KEGG pathways that were consistently represented across all six studies. Expression levels of the 193 KEGG pathways were then color-coded and visualized, using the Genesis software package (29) . Overrepresentation of specific transcription factor and miRNA binding sites as well as KEGG pathways in a gene set was statistically analyzed by a hypergeometric test incorporated into WebGestalt. A flowchart of the experimental design is shown in Fig. 2 .
RESULTS
Comparison of the transcriptome in early vs. late HF. Figure 3 displays significant quantitative differences in gene expression patterns between the various time points. While there was an equal number of up-or downregulated genes in the gradual group, significant differences existed in numbers of up-or downregulated transcripts between early and late HF groups. Downregulation was more common among early HF genes, while the opposite held true for late HF transcripts (Fig. 4A) . We (3, 10) and others (28) have reported that metabolic gene classes are downregulated, whereas cell signaling pathways involved with chamber remodeling and fibrosis are upregulated in end-stage HF. We found the majority of metabolic gene classes, including oxidative phosphorylation, tricarboxylic acid cycle (TCA cycle), glucose and fatty acid metabolism were By contrast, transcripts of multiple signaling pathways, including transforming growth factor-beta and extracellular remodeling, p53 signaling, mitogen-activated protein kinase pathways, and apoptosis were upregulated predominantly in late HF (Figs. 4C and 6, A-H). Strikingly, many of these major signaling pathways altered in late HF displayed a biphasicbidirectional course with changes in the opposite direction earlier in the course of the disease (Figs. 4C and 6, A-H). For instance, the KEGG pathway of vascular smooth muscle contraction included subunits of the protein kinase C (eta and theta), catalytic beta cAMP-dependent protein kinase, beta1 phospholipase C subunit, adenylate cyclase 4 and 9, adenosine A2a receptor, inositol 1,4,5-triphosphate receptors 1 and 2, smooth muscle myosin heavy polypeptide 11, regulatory myosin light polypeptide 9, and myosin light polypeptide kinase, all of which exhibited a biphasic bidirectional pattern (first down-, then upregulated). While we could define specific KEGG pathways characteristic of transcripts expressed with early, gradual, late, and BID HF patterns, no specific functional classes were assignable to early transient transcripts (Fig. 4A) , suggesting the latter genes likely reflected nonspecific stress responses. Transcripts involved with mRNA metabolism and splicing were upregulated across all stages of HF (transient, early, late, and gradual; Fig. 7A ). This indicates alternative splicing is likely a major source of protein diversity starting from the early HF stages. Upregulation of ribosomal components in early, gradual, and late HF stages indicates a concomitant demand for increased protein synthesis (Fig. 7B) .
Differences in transcriptional regulation. The distinct pattern of early (down) vs. late (up) regulation of most signaling pathways suggested coordinated transcriptional regulation that is likely controlled by different sets of transcription factors and/or miRNAs at different times of the disease process. We therefore tested whether early and late HF transcripts showed differences in the predominance of specific regulatory regions. Consistent with prior reports (6), we found that genes with transcription factor binding sites have a higher probability of being targeted by miRNAs as they generally have more miRNA-binding sites as well (Fig. 8, A and B) . Additionally, early upregulated transcripts contained significantly more transcription factor and miRNA binding sites compared with late upregulated genes. MiRNA and transcription factor binding sites were more abundant in upregulated genes compared with downregulated genes (Fig. 8, A and B) .
Transcription factor binding sites identified from genes at the different time points are highlighted in Fig. 9 , A and B. Downregulated transcripts in early, gradual, and late HF groups showed a high prevalence of estrogen-related receptor-␣ (Err1, Esrra) transcription factor binding sites (TFBS) in their promoters. Esrra is a key regulatory partner of Pgc-1␣ (peroxisome proliferator-activated receptor-␥ coactivator 1␣, Ppargc1a) which is implicated in downregulation of mitochondrial metabolic capacity in HF (28) . Both Esrra and Ppargc1a were downregulated in early HF (Supplementary Table S1 ) along with Esrra target genes (Supplementary Table S2 ). 1 Likewise expression of Mef2 and its target genes also declined across different stages of HF (Fig. 9A and Supplementary  Tables S1-S3 ). In addition to Pgc-1␣, Mef2 is predicted to bind in the promoter region of a wide variety of other genes with metabolic function, including succinate dehydrogenase complex c (Sdhc), aldolase A (Aldoa), enolase 3 (Eno3), glucokinase (hexokinase 4, Gck), and phosphoglycerate mutase 2 (Pgam2). The downregulation of metabolic genes in 1 The online version of this article contains supplemental material.
Heart failure studies (HF, n=6) with time-course data in GEO:
(1) CONTROL (non-failing) (2) EARLY HF (less than 3 days after cardiac insult) Fig. 4B ), metabolic pathways were predominantly downregulated in the gradual and early HF groups, but not in late HF (*P Ͻ 0.05). NS, not significant. early and gradual HF is accompanied by downregulation of sarcomeric genes, all of which are predicted to be Mef2 targets, too, including troponin I, C, and T isoforms (Tnnc1, Tnni3, Tnnt1, Tnnt2), myosin light chain 2 and 3 (Myl2 and Myl3), and myosin heavy chain 6 (Myh6; Supplemental Table S3) , thus, supporting the central role of Mef2 transcription in cardiac pathophysiology.
In contrast, a different set of factors, E2f and ETS family members (E-Twenty Six, including Gabp, Elf1, and Ets2) as well as serum response (Srf) and interferon-regulated factor (Irf) were prevalent in upregulated transcripts in late-HF (Fig.  9B and Supplementary Tables S1 and S2 ).
In addition to transcription factors, miRNAs have been recognized as central regulators of gene expression. In endstage HF, miRNA-1, -9, -22, -133a/b, -150, -378, and -499 are all reported to be downregulated (1, 5, 15, 25, 26, 32) . Based on bioinformatics of potential miRNA target genes, we determined that sequences likely targeted by miRNA-1, -9, and -499 were overrepresented in gradual and late, but not early upregulated HF genes, whereas miRNA-22, -133a/b, -150, and -378 sites were found in transcripts upregulated in early and transient HF (Fig. 10B and Supplemental Table S4 ). Downregulation of miR-1 in HF is well established (5, 15, 25) , and progressive downregulation of miR-1 during the development of cardiac hypertrophy and failure (26) correlates well with the upregulation of miR-1 target genes observed in the gradual and late HF groups in the current analysis. In contrast, miRNA sites for miR-522 were overrepresented in early, gradual, and late upregulated HF genes, suggesting that this miRNA is downregulated across all stages of HF.
DISCUSSION
The majority of gene expression studies in HF have focused on comparisons between nonfailing and end-stage failing myocardium (3). The purpose of the present study was to establish a robust time course for ventricular gene expression in HF by examining the underappreciated early time window, i.e., 2-3 days after a cardiac insult when transcriptional changes are apparent in the absence of classic phenotypic changes of HF (10) . We found gene expression patterns in early and late HF differ both quantitatively and qualitatively, identifying distinct temporal gene expression patterns in evolving HF.
Early and sustained downregulation of metabolic pathways in HF. Consistent with previous studies (3, 27) , we noted that end-stage HF is characterized by downregulation of transcripts encoding for metabolic processes. The observation that the majority of metabolic pathways showed pronounced downregulation in early and gradual HF, but not in late HF (Figs. 4A  and 5, A-D) supports the idea that metabolic abnormalities are an early event in HF (3, 27, 30) . This downregulation was likely coordinated by a small set of transcription factors, most prominently Esrra and Mef2, which affect Pgc-1␣, a master regulator of mitochondrial biogenesis and fatty acid oxidation (7, 28) . In line with these findings, Mef2a-deficient mice display reduced viable mitochondria and high postnatal mortality (22) , whereas hearts from Esrra-deficient mice have abnormal phosphocreatine depletion and a functional decline when subjected to hemodynamic stress (14) .
Biphasic-bidirectional transcriptional activation of signaling pathways. A surprising and striking observation from our time-course data was that many of the major signaling pathways (e.g., MAPK, calcium, and p53 signaling, as well as apoptosis) altered in late-stage HF displayed a biphasic course with changes in the completely opposite direction earlier in the course of disease. Results obtained from human and mouse data affirm that genes with a switch-like or bimodal expression play a large role in cell communication and are enriched for functions in extracellular and intercellular signal transduction (9, 13). To our knowledge, extensive bidirectional transcriptional regulation in HF has not been previously appreciated. This has been described for some individual genes, such as Gi-␣2 in a rat model of catecholamine stimulation (down early, then up) (20) , or group II phospholipase A2 (Pla2), which regulates many inflammatory processes and had a biphasic pattern in rat hearts with early vs. late sepsis (19, 33) . In HF, the early transient response has been regarded as beneficial, while the later response is thought to be detrimental (4, 18, 24) . In contrast, genes whose expression changed either very early or more gradually but ended up in the same direction at the later HF time point are more likely to play a dominant role in HF progression. The molecular mechanisms of biphasic-bidirectional transcriptional regulation in HF may reflect competing controlling inputs. Transcription factors rarely ever act alone but usually form complexes with other transcription factors by promoting (as activators) or blocking (as repressors) recruitment of RNA polymerase. Thus, it is conceivable that the composition of the transcription factor complex changes as different factors are recruited or dissociate from the complex during early downand late upregulation. Alternatively, epigenetic modification in promoter regions during the progression of HF could lead to differential binding of the same transcription factors during early and late HF stages, thereby shifting the balance between up-and downregulation using the same transcription factors. Interestingly, the promoter regions of signaling pathway transcripts were enriched in E2f binding sites that encode for a family of factors that act as both activators (E2f1, E2f2, and E2f3a) and suppressors (E2f3b, E2f4 -8). In line with this concept, we found upregulation in the late-up and BID down-up groups of members of the E2f family with activating and suppressing properties (E2f1, E2f3, and E2f8; see Supplementary Table S1 ), highlighting the complex and dynamic balance of the gene regulatory networks in both groups. Study limitations. Given that the current study focused on the early and transient gene expression changes in the first 2-3 days after a cardiac insult, intermediate time points between the early and late response were not available for all studies. Thus, the late response, which develops after day 3, could occur as early as day 4 or 5, but possibly also at later stages of the disease when phenotypic changes of HF are most pronounced. Our previous study in canine tachypacing, which examined dogs after 3, 7, 14, and 21 days of tachypacing, suggested that the majority of the gene expression changes occur within the first week (10) . This is in line with a gene expression study of tachypaced dogs showing that the transition from compensated cardiac dysfunction to clinically decompensated HF was associated with few additional changes in the cardiac transcriptome (23) .
Conversely, the early transcriptional phase only included the time period 2-3 days after the initial cardiac insult. As transcriptional changes are expected to occur within minutes to hours after a cardiac insult, these very early transcriptional events are not accounted for in the current study. Future studies are needed to address the role of these earlier time points.
Additionally, the definition of the early time period included transcriptional changes over a 48-h period (day 2 and 3), and we have found that transcriptional processes vary in part between day 2 and 3 in our MCM model (Fig. 11) . As different HF models could show a different time course of gene expression in day 2 and day 3, we chose to combine data from this early gene expression window across different HF models to extract a common and more robust denominator that is representative of early gene expression irrespective of the underlying etiology of HF.
Conclusions. In summary, we demonstrate that during the development of HF, gene expression is characterized by dynamic overlapping sets of transcripts controlled by specific interrelated regulatory mechanisms. While metabolic gene classes show early and sustained downregulation, signaling pathways undergo a complex biphasic pattern with early downand more pronounced late upregulation. A better understanding of the complex phenotypic response in HF and its associated temporal gene expression changes will help differentiate adaptive from maladaptive processes and is a prerequisite to develop targeted therapeutic strategies to modulate disease pathophysiology. Future studies will need to test the hypothesis that early transient downregulation of signaling pathways are adaptive and beneficial, while the late sustained upregulation is maladaptive.
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